This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Dana-Farber-Cancer Institute Inc., Medical University of Lodz, The Brigham and Women's Hospital, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2025
Title: Wojciech Fendler: Innovator in Ovarian Cancer Research
Introduction
Wojciech Fendler is a notable inventor based in Lodz, Poland, recognized for his contributions to the field of cancer research. He has been instrumental in developing innovative methods for detecting ovarian cancer through microRNA biomarkers. With a total of 2 patents, Fendler's work has the potential to significantly impact the diagnosis and treatment of this serious condition.
Latest Patents
Fendler's latest patents focus on "Circulating microRNA signatures for ovarian cancer." These patents provide methods and kits for determining the presence or absence of specific microRNA biomarkers in blood samples from female patients. The biomarkers identified are closely associated with ovarian cancer. Additionally, the patents outline methods for screening female subjects for these biomarkers and offer approaches for treating those diagnosed with ovarian cancer.
Career Highlights
Throughout his career, Wojciech Fendler has worked with prestigious institutions such as Dana-Farber Cancer Institute Inc. and Brigham and Women's Hospital, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Fendler has collaborated with notable colleagues, including Dipanjan Chowdhury and Kevin M Elias. These partnerships have further enhanced his research and innovation in the area of cancer diagnostics.
Conclusion
Wojciech Fendler's work in ovarian cancer research exemplifies the importance of innovation in medical science. His patents and collaborations reflect a commitment to improving patient outcomes through advanced diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile